Tasso, Inc. Announces Duncan Porter as Senior Vice President of Growth
Industry veteran brings decades of healthcare technology leadership to the company
SEATTLE – April 6, 2023 – Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the appointment of Duncan Porter as Senior Vice President of Growth, reporting to Tasso’s CEO Ben Casavant. Porter will lead Tasso's international expansion, building upon the recent CE regulatory approval of their TassoOne™ Plus and Tasso-M20 devices.
Tasso’s signature line of virtually painless, remote blood collection devices and integrated logistics platform empower pharmaceutical companies, healthcare providers, governmental organizations, and more to expand patient access. With demand for convenient, patient-centric care continuing to grow worldwide, Tasso is well positioned to expand into new global markets under Porter’s lead.
Duncan Porter, Senior Vice President of Growth
"Duncan is an exceptional leader who brings a wealth of experience in growth strategy and international expansion," said Ben Casavant, PhD, CEO and co-founder of Tasso. "We are thrilled to have him join our team to drive our mission of reaching patients worldwide."
Porter brings to Tasso more than 20 years of experience in strategic marketing, business development, and general management within the healthcare technology space. Most recently, he served as the General Manager for the Global Sample Collection and Transport business unit at Thermo Fisher, leading transformation programs during the pandemic. Prior to Thermo Fisher he held various senior leadership positions at Philips and holds an MBA from Warwick University.
"I am excited to join Tasso at this pivotal moment in the company's growth," said Porter. "Tasso’s unique portfolio is already powering the transition to decentralisation of clinical trials. There is great potential to transform clinical diagnostics by providing a patient-centric, remote sampling solution that enables greater access to critical diagnostic tests. I look forward to working with the team to drive growth and expand the reach of this ground-breaking technology."
Tasso products are now available in select European regions. For more information on Tasso, please visit www.tassoinc.com.
About Tasso
Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders. For more information, please visit www.tassoinc.com.
Media Contact
Dina Schneider
(206) 822-4186 x1016
Commercial Contact
RJ Asplund
(818) 434-5004